IL127304A - Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression - Google Patents

Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression

Info

Publication number
IL127304A
IL127304A IL12730497A IL12730497A IL127304A IL 127304 A IL127304 A IL 127304A IL 12730497 A IL12730497 A IL 12730497A IL 12730497 A IL12730497 A IL 12730497A IL 127304 A IL127304 A IL 127304A
Authority
IL
Israel
Prior art keywords
preparation
medicaments
depression
pharmaceutical compositions
treating anxiety
Prior art date
Application number
IL12730497A
Other languages
English (en)
Other versions
IL127304A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL127304A0 publication Critical patent/IL127304A0/xx
Publication of IL127304A publication Critical patent/IL127304A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL12730497A 1996-06-20 1997-06-16 Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression IL127304A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612885.5A GB9612885D0 (en) 1996-06-20 1996-06-20 Novel compounds
PCT/EP1997/003157 WO1997048700A1 (en) 1996-06-20 1997-06-16 Indoline derivatives useful as 5-ht-2c receptor antagonists

Publications (2)

Publication Number Publication Date
IL127304A0 IL127304A0 (en) 1999-09-22
IL127304A true IL127304A (en) 2003-07-06

Family

ID=10795577

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12730497A IL127304A (en) 1996-06-20 1997-06-16 Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression

Country Status (28)

Country Link
US (2) US6313145B1 (no)
EP (1) EP0912556B1 (no)
JP (1) JP2000512644A (no)
KR (1) KR20040101563A (no)
CN (1) CN1147485C (no)
AR (1) AR008244A1 (no)
AT (1) ATE196766T1 (no)
AU (1) AU718000B2 (no)
BR (1) BR9709982A (no)
CA (1) CA2258559A1 (no)
CO (1) CO4870758A1 (no)
CZ (1) CZ289799B6 (no)
DE (1) DE69703242T2 (no)
DK (1) DK0912556T3 (no)
ES (1) ES2152682T3 (no)
GB (1) GB9612885D0 (no)
GR (1) GR3034847T3 (no)
HK (1) HK1019744A1 (no)
HU (1) HUP9903480A3 (no)
IL (1) IL127304A (no)
NO (1) NO316756B1 (no)
NZ (1) NZ332840A (no)
PL (1) PL186885B1 (no)
PT (1) PT912556E (no)
TR (1) TR199802552T2 (no)
TW (1) TW360650B (no)
WO (1) WO1997048700A1 (no)
ZA (1) ZA975416B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710523D0 (en) * 1997-05-23 1997-07-16 Smithkline Beecham Plc Novel compounds
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
AU2002346507A1 (en) 2001-11-28 2003-06-10 Pharmacia And Upjohn Company Benzazepine derivatives and their use as 5-ht ligands
GB0200283D0 (en) * 2002-01-08 2002-02-20 Smithkline Beecham Plc Compounds
JP2006506319A (ja) 2002-03-04 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 5−ht受容体リガンドとしてのピリジニルオキシ誘導体
EP1497265B1 (en) * 2002-04-19 2009-02-18 Glaxo Group Limited Compounds having affinity at 5ht2c receptor and use thereof in therapy
GB0305024D0 (en) * 2003-03-05 2003-04-09 Glaxo Group Ltd Compounds
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
KR20110114664A (ko) 2009-01-16 2011-10-19 메사추세츠 인스티튜트 오브 테크놀로지 자폐 스펙트럼 장애의 진단 및 치료

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4704693A (en) 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
ES2151652T3 (es) * 1995-02-02 2001-01-01 Smithkline Beecham Plc Derivados de indol como antagonistas del receptor 5ht.
EP0807104A2 (en) 1995-02-02 1997-11-19 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
GB9607219D0 (en) 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP

Also Published As

Publication number Publication date
EP0912556A1 (en) 1999-05-06
JP2000512644A (ja) 2000-09-26
CN1222152A (zh) 1999-07-07
CZ289799B6 (cs) 2002-04-17
GB9612885D0 (en) 1996-08-21
PT912556E (pt) 2001-02-28
US6313145B1 (en) 2001-11-06
US20020035134A1 (en) 2002-03-21
PL186885B1 (pl) 2004-03-31
DE69703242T2 (de) 2001-03-08
HK1019744A1 (en) 2000-02-25
HUP9903480A2 (en) 2000-07-28
KR20040101563A (ko) 2004-12-02
DK0912556T3 (da) 2001-01-22
TR199802552T2 (xx) 1999-02-22
AU3339697A (en) 1998-01-07
HUP9903480A3 (en) 2002-12-28
ZA975416B (en) 1999-01-25
WO1997048700A1 (en) 1997-12-24
TW360650B (en) 1999-06-11
NO316756B1 (no) 2004-04-26
DE69703242D1 (de) 2000-11-09
NO985970L (no) 1998-12-18
AU718000B2 (en) 2000-04-06
IL127304A0 (en) 1999-09-22
CN1147485C (zh) 2004-04-28
PL330708A1 (en) 1999-05-24
NZ332840A (en) 2000-05-26
GR3034847T3 (en) 2001-02-28
CO4870758A1 (es) 1999-12-27
ES2152682T3 (es) 2001-02-01
EP0912556B1 (en) 2000-10-04
BR9709982A (pt) 1999-08-10
CZ420498A3 (cs) 1999-05-12
AR008244A1 (es) 1999-12-29
NO985970D0 (no) 1998-12-18
ATE196766T1 (de) 2000-10-15
CA2258559A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
EE9700153A (et) Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700060A (et) 2-arüül-asendatud püridiinid,nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
HUP9602122A3 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUT76286A (en) Quinoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
IL131163A (en) Heteroaryl-hexanoic acid amide derivatives, their use in the preparation of medicaments, and pharmaceutical compositions comprising them
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
IL133784A (en) Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer
HUP0002404A3 (en) Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use
HU9800781D0 (en) Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
IL127304A (en) Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
HUP9901434A3 (en) Substituted benzylamines and their use for the preparation of medicaments for treating depression
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees